Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA
- PMID: 19155227
- PMCID: PMC2640158
- DOI: 10.1093/jac/dkn547
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA
Abstract
Background: The emergence of bla(KPC)-containing Klebsiella pneumoniae (KPC-Kp) isolates is attracting significant attention. Outbreaks in the Eastern USA have created serious treatment and infection control problems. A comparative multi-institutional analysis of these strains has not yet been performed.
Methods: We analysed 42 KPC-Kp recovered during 2006-07 from five institutions located in the Eastern USA. Antimicrobial susceptibility tests, analytical isoelectric focusing (aIEF), PCR and sequencing of bla genes, PFGE and rep-PCR were performed. Results By in vitro testing, KPC-Kp isolates were highly resistant to all non-carbapenem beta-lactams (MIC(90)s >or= 128 mg/L). Among carbapenems, MIC(50/90)s were 4/64 mg/L for imipenem and meropenem, 4/32 mg/L for doripenem and 8/128 for ertapenem. Combinations of clavulanate or tazobactam with a carbapenem or cefepime did not significantly lower the MIC values. Genetic analysis revealed that the isolates possessed the following bla genes: bla(KPC-2) (59.5%), bla(KPC-3) (40.5%), bla(TEM-1) (90.5%), bla(SHV-11) (95.2%) and bla(SHV-12) (50.0%). aIEF of crude beta-lactamase extracts from these strains supported our findings, showing beta-lactamases at pIs of 5.4, 7.6 and 8.2. The mean number of beta-lactamases was 3.5 (range 3-5). PFGE demonstrated that 32 (76.2%) isolates were clonally related (type A). Type A KPC-Kp isolates (20 bla(KPC-2) and 12 bla(KPC-3)) were detected in each of the five institutions. rep-PCR showed patterns consistent with PFGE.
Conclusions: We demonstrated the complex beta-lactamase background of KPC-Kp isolates that are emerging in multiple centres in the Eastern USA. The prevalence of a single dominant clone suggests that interstate transmission has occurred.
Figures


Similar articles
-
Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system.J Antimicrob Chemother. 2009 Nov;64(5):1102-10. doi: 10.1093/jac/dkp327. Epub 2009 Sep 9. J Antimicrob Chemother. 2009. PMID: 19740911 Free PMC article.
-
Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.J Antimicrob Chemother. 2009 Apr;63(4):654-8. doi: 10.1093/jac/dkp018. Epub 2009 Feb 13. J Antimicrob Chemother. 2009. PMID: 19218573
-
Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.J Antimicrob Chemother. 2009 Aug;64(2):348-52. doi: 10.1093/jac/dkp207. Epub 2009 Jun 13. J Antimicrob Chemother. 2009. PMID: 19525514
-
Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.Microb Drug Resist. 2011 Jun;17(2):251-7. doi: 10.1089/mdr.2010.0116. Epub 2011 Feb 19. Microb Drug Resist. 2011. PMID: 21332362
-
Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary.Eur J Clin Microbiol Infect Dis. 2010 Jul;29(7):765-9. doi: 10.1007/s10096-010-0921-3. Epub 2010 Apr 18. Eur J Clin Microbiol Infect Dis. 2010. PMID: 20401676
Cited by
-
The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.Clin Microbiol Rev. 2015 Jul;28(3):565-91. doi: 10.1128/CMR.00116-14. Clin Microbiol Rev. 2015. PMID: 25926236 Free PMC article. Review.
-
Epidemiology and resistance mechanisms to imipenem in Klebsiella pneumoniae: a multicenter study.Mol Med Rep. 2013 Jan;7(1):21-5. doi: 10.3892/mmr.2012.1155. Epub 2012 Oct 25. Mol Med Rep. 2013. PMID: 23128404 Free PMC article.
-
In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.Antimicrob Agents Chemother. 2010 Jan;54(1):526-9. doi: 10.1128/AAC.01235-09. Epub 2009 Nov 9. Antimicrob Agents Chemother. 2010. PMID: 19901089 Free PMC article.
-
Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections.Int J Infect Dis. 2014 Aug;25:73-8. doi: 10.1016/j.ijid.2014.01.028. Epub 2014 May 9. Int J Infect Dis. 2014. PMID: 24813874 Free PMC article.
-
Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II.Clin Infect Dis. 2016 Jan 15;62(2):181-9. doi: 10.1093/cid/civ837. Epub 2015 Sep 25. Clin Infect Dis. 2016. PMID: 26409063 Free PMC article.
References
-
- Walther-Rasmussen J, Hoiby N. Class A carbapenemases. J Antimicrob Chemother. 2007;60:470–82. - PubMed
-
- Landman D, Bratu S, Kochar S, et al. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J Antimicrob Chemother. 2007;60:78–82. - PubMed
-
- Deshpande LM, Jones RN, Fritsche TR, et al. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY antimicrobial surveillance program (2000–2004) Microb Drug Resist. 2006;12:223–30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources